Detalles de la búsqueda
1.
OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition.
Acta Pharmacol Sin
; 37(10): 1359-1369, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27264313
2.
Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect.
Sci Rep
; 6: 28676, 2016 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339735
Resultados
1 -
2
de 2
1
Próxima >
>>